Lea Humphrey, DO
Otolaryngology/Facial Plastic Surgery · Tahlequah, OKNPI 1649584855
Payments from drug & device makers
What this record shows
This record is dominated by food and beverage: $1,323 of the $1,511 with a category attached, or 87.6%. It is spread thinly across 16 manufacturers, the largest accounting for just 20.8% — the pattern of someone who eats at a lot of different presentations.
Across 63 payments — averaging $23.99 each. Meals, travel, consulting and speaking fees, gifts and royalties reported by drug and device makers.
- Sanofi$314
- Sanofi-aventis U.S. LLC$270
- Stryker$220
- Regeneron Healthcare Solutions, Inc.$145
- Medtronic$128
- GSK$103
- plus $332 from 10 others
What the payments were for
- Food & beverage$1,32388%
- Education$18812%
Most of this is food and beverage — typically meals provided during product presentations at a clinic or hospital. Nationally that is the single largest category of reported payments by count.
General payments by program year
Who reported the general payments
Companies are grouped under their corporate parent — a single manufacturer often files under several CMS reporting entities. Research and ownership payments are counted separately and are not in this table.
| Company | Payments | Total |
|---|---|---|
| Sanofi | 15 | $314 |
| Sanofi-aventis U.S. LLC | 6 | $270 |
| Stryker | 6 | $220 |
| Regeneron Healthcare Solutions, Inc. | 7 | $145 |
| Medtronic(2 entities) | 2 | $128 |
| GSK | 7 | $103 |
| Alk-abello, Inc | 3 | $59 |
| Intersect ENT, Inc. | 4 | $53 |
| Novartis | 3 | $51 |
| Acclarent, Inc | 1 | $38 |
| Kaleo, Inc. | 2 | $28 |
| Shire North American Group Inc | 2 | $28 |
| AstraZeneca | 2 | $27 |
| Inspire Medical Systems, Inc. | 1 | $18 |
| Phadia US Inc. | 1 | $17 |
| Genentech USA, Inc. | 1 | $12 |
What the payments were tied to
Products named in the reported payments. Only payments of $100 or more are attributed here — the typical reported payment nationally is a meal worth about $16, and listing those product-by-product would be noise.
- FUSION$109
How this compares
Too few otolaryngology/facial plastic surgery providers in Oklahomato place this figure against a meaningful peer group, so we don't.
Medicare billing
What this is not: this is the amount Original Medicare Part B allowed for services this provider billed in 2024. It is not their income. It excludes Medicare Advantage — now more than half of all Medicare enrollment — along with Medicaid and all commercial insurance, and it is gross practice revenue before staff, rent, supplies and malpractice premiums. CMS also suppresses any figure covering ten or fewer patients, so low-volume providers appear smaller than they are.
Most prescribed under Part D
| Drug | Claims | Cost to plans & patients |
|---|---|---|
| XolairOmalizumab | 20 | $96,842 |
| Dupixent PenDupilumab | 13 | $57,550 |
| Epinephrine | 36 | $7,176 |
| Famotidine | 353 | $5,525 |
| Fluticasone Propionate | 371 | $4,438 |
| Azelastine Hcl | 122 | $2,963 |
| Omeprazole | 179 | $2,767 |
| Ipratropium Bromide | 75 | $1,818 |
| Pantoprazole Sodium | 94 | $776 |
| Ofloxacin | 56 | $671 |
| Esomeprazole Magnesium | 22 | $655 |
| Clotrimazole | 15 | $378 |
| CefuroximeCefuroxime Axetil | 22 | $374 |
| Mupirocin | 27 | $230 |
| Montelukast Sodium | 38 | $177 |
Paid to pharmacies, not to this prescriber.
Other otolaryngology/facial plastic surgery in Tahlequah
- Tracey ChildersTahlequah$896
- Mark MimsOklahoma City$7K
- Jean-Maria LangleyTulsa$5K
- Bryan SmedleyOwasso$3K
- Caleb BurrowsBroken Arrow$3K
- Joe LandrumAda$1K
- Troy MajorOklahoma City$661
- Chase NelsonTulsa$117
- Paul HunterOklahoma City$15
Where these figures come from
- Payments: CMS Open Payments, program years 2019–2025 (publication P06302026_06032026).
- Billing: Medicare Physician & Other Practitioners, data year 2024. Original Medicare Part B only.
- Identity: NPPES NPI Registry, July 2026.